Home > Publications Database > Preparing n-of-1 Antisense Oligonucleotide Treatments for Rare Neurological Diseases in Europe: Genetic, Regulatory, and Ethical Perspectives. > Access to Fulltext |
![]() |
|||||||
version 1 |
|